Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for CHECKPOINT-INHIBITOR UND GANZZELLIGES MYCOBAKTERIUM ZUR VERWENDUNG IN DER KREBSTHERAPIE
Details for 2016734013
Up to date per 10.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2016734013
Title / Product Name
CHECKPOINT-INHIBITOR UND GANZZELLIGES MYCOBAKTERIUM ZUR VERWENDUNG IN DER KREBSTHERAPIE
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2016734013
EP Publication Number
3319635
E-Number
1383938
Language
EN
PCT Number
GB16051893
Publication Date
16.05.2018 A
21.04.2021 B1
Registration Date
21.04.2021
AT Publication Date
15.05.2021
Application Date
24.06.2016
Registration Number
-
Priorities
24.06.2015
GB
201511120
24.06.2015
GB
201511121
IPC
A61K 39/395 20060101AFI20170110BHEP
Maximum Duration of Protection
24.06.2036
Owner
Immodulon Therapeutics Limited
6-9 The Square Stockley Park
Uxbridge UB11 1FW
GB
Representative
Representative
Babeluk Patentanwälte GmbH
Florianigasse 26/3
1080 Wien
AT
Inventor
AKLE, Charles
Immodulon Therapeutics Limited 6-9 The Square Stockley Park
Uxbridge UB11 1FW
GB
BRUNET, Laura Rosa
Immodulon Therapeutics Limited 6-9 The Square Stockley Park
Uxbridge UB11 1FW
GB
Information about Fees
Click here to load the fees